Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Posterior Reversible Encephalopathy Syndrome With Concurrent Nephrotic Syndrome in a Patient Treated With Pazopanib for Metastatic Renal Cell Carcinoma: Case Report and Review of the Literature.
Miaris N, Maltezou M, Papaxoinis G, Visvikis A, Samantas E. Miaris N, et al. Among authors: samantas e. Clin Genitourin Cancer. 2017 Feb;15(1):e99-e103. doi: 10.1016/j.clgc.2016.08.005. Epub 2016 Aug 10. Clin Genitourin Cancer. 2017. PMID: 27601362 Review. No abstract available.
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer.
Pectasides D, Karavasilis V, Papaxoinis G, Gourgioti G, Makatsoris T, Raptou G, Vrettou E, Sgouros J, Samantas E, Basdanis G, Papakostas P, Bafaloukos D, Kotoula V, Kalofonos HP, Scopa CD, Pentheroudakis G, Fountzilas G. Pectasides D, et al. Among authors: samantas e. BMC Cancer. 2015 May 10;15:384. doi: 10.1186/s12885-015-1406-7. BMC Cancer. 2015. PMID: 25956750 Free PMC article. Clinical Trial.
Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping.
Papaxoinis G, Kotoula V, Giannoulatou E, Koliou GA, Karavasilis V, Lakis S, Koureas A, Bobos M, Chalaralambous E, Daskalaki E, Chatzopoulos K, Tsironis G, Pazarli E, Chrisafi S, Samantas E, Kaklamanos IG, Varthalitis I, Konstantara A, Syrigos KN, Pentheroudakis G, Pectasides D, Fountzilas G. Papaxoinis G, et al. Among authors: samantas e. Med Oncol. 2018 May 31;35(7):101. doi: 10.1007/s12032-018-1160-1. Med Oncol. 2018. PMID: 29855806 Clinical Trial.
Patterns of practice and pharmacoeconomic analysis of the management of patients with metastatic renal cell carcinoma (mRCC) in Greece--the CRISIS study. A retrospective analysis by the Hellenic Genitourinary Cancer Group (HGUCG).
Tsironis G, Koutsoukos K, Athanasakis K, Tsiara A, Tzannis K, Gerolympou M, Visvikis A, Oikonomopoulos G, Kollia A, Giannopoulou E, Dimitra M, Kostouros E, Papatsoris A, Dellis A, Stravodimos K, Varkarakis I, Samantas E, Aravantinos G, Kentepozidis N, Christodoulou C, Bozionelou V, Dimopoulos MA, Bamias A. Tsironis G, et al. Among authors: samantas e. Expert Rev Pharmacoecon Outcomes Res. 2019 Aug;19(4):491-501. doi: 10.1080/14737167.2019.1546121. Epub 2018 Nov 19. Expert Rev Pharmacoecon Outcomes Res. 2019. PMID: 30417707
Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma.
Fountzilas E, Eliades A, Koliou GA, Achilleos A, Loizides C, Tsangaras K, Pectasides D, Sgouros J, Papakostas P, Rallis G, Psyrri A, Papadimitriou C, Oikonomopoulos G, Ferentinos K, Koumarianou A, Zarkavelis G, Dervenis C, Aravantinos G, Bafaloukos D, Kosmidis P, Papaxoinis G, Theochari M, Varthalitis I, Kentepozidis N, Rigakos G, Saridaki Z, Nikolaidi A, Christopoulou A, Fostira F, Samantas E, Kypri E, Ioannides M, Koumbaris G, Fountzilas G, Patsalis PC. Fountzilas E, et al. Among authors: samantas e. Cancers (Basel). 2021 Jan 8;13(2):198. doi: 10.3390/cancers13020198. Cancers (Basel). 2021. PMID: 33429865 Free PMC article.
Investigation of prognostic biomarkers in patients with urothelial carcinoma treated with platinum-based regimens.
Papadopoulou K, Koliou GA, Tsimiliotis D, Kotoula V, Foukas P, Goussia A, Tsiatas M, Visvikis A, Chatzopoulos K, Nifora M, Charchanti A, Koumarianou A, Christodoulou C, Pectasides D, Psyrri A, Fostira F, Fountzilas G, Samantas E. Papadopoulou K, et al. Among authors: samantas e. Urol Oncol. 2022 Dec;40(12):538.e15-538.e24. doi: 10.1016/j.urolonc.2022.07.007. Epub 2022 Aug 28. Urol Oncol. 2022. PMID: 36041976
Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer.
Pentheroudakis G, Kotoula V, Kouvatseas G, Charalambous E, Dionysopoulos D, Zagouri F, Koutras A, Papazisis K, Pectasides D, Samantas E, Dimopoulos MA, Papandreou CN, Fountzilas G. Pentheroudakis G, et al. Among authors: samantas e. Clin Breast Cancer. 2014 Oct;14(5):330-8. doi: 10.1016/j.clbc.2014.02.009. Epub 2014 Mar 1. Clin Breast Cancer. 2014. PMID: 24703319 Clinical Trial.
169 results